ArticleTherapeutic advances in medical oncology2021

Clinical sequencing to assess tumor mutational burden as a useful biomarker to immunotherapy in various solid tumors.

Hana Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.